Peringkat dalam Saham
#30384
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Harga Saham
$1.25
Terakhir disinkronkan: 2026-08-18
Kapitalisasi Pasar
$17.05M
Perubahan (1 hari)
-1.50%
Perubahan (1 tahun)
-22.24%
Perdagangan Aelis Farma S.A. (AELIS)
Harga AELIS dengan kapitalisasi pasar B
Kapitalisasi pasar dari Aelis Farma S.A.(AELIS)
Kapitalisasi Pasar: $17.05M
Per August 2026, Aelis Farma S.A. memiliki kapitalisasi pasar sebesar $17.05M. Ini menjadikan Aelis Farma S.A. sebagai perusahaan 30384th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Aelis Farma S.A. dari 2022 hingga 2026
AELIS dibandingkan dengan 5 teratas stocks paling populer
| Harga AELIS |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.307T
|
+31,129,810.13%
|
|
|
|
|
$4.551T
|
+26,695,786.97%
|
|
|
|
|
$4.154T
|
+24,370,577.33%
|
|
|
|
|
$3.589T
|
+21,051,335.33%
|
|
|
|
|
$2.797T
|
+16,406,999.17%
|
